Literature DB >> 11744904

Expression of estrogen receptor isoforms alpha and beta messenger RNA in vaginal tissue of premenopausal and postmenopausal women.

J B Gebhart1, D J Rickard, T J Barrett, T G Lesnick, M J Webb, K C Podratz, T C Spelsberg.   

Abstract

OBJECTIVE: To determine the messenger RNA expression patterns of estrogen receptor (ER)alpha and ER beta in human vaginal tissue. STUDY
DESIGN: Reverse transcriptase-polymerase chain reaction was performed on tissue samples of 75 patients having anterior colporrhaphy (25 premenopausal, 25 postmenopausal receiving estrogen replacement therapy [ERT], 25 postmenopausal not receiving ERT). Levels of mRNA were normalized and ratios were calculated to assess relative levels of expression.
RESULTS: All samples showed expression of the ER alpha isoform. Significant differences existed in ER alpha expression among the 3 cohorts (P =.023). Greater differences (P <.001) existed in ER beta expression. For both isoforms, the premenopausal group had the highest level, and the postmenopausal group receiving ERT had the lowest level. No significant difference in ER beta expression existed between postmenopausal groups.
CONCLUSION: Significant differences exist between premenopausal and postmenopausal women in presence and expression of ER alpha and ER beta in vaginal tissue. Expression of ER beta markedly declines in menopause, regardless of ERT use.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11744904     DOI: 10.1067/mob.2001.119627

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  15 in total

1.  The effect of raloxifene, a SERM, on extracellular matrix protein expression of pelvic fibroblasts.

Authors:  Jung Han Lee; Yan Wen; Mary Lake Polan; Bertha Chen
Journal:  Int Urogynecol J       Date:  2011-09-21       Impact factor: 2.894

Review 2.  Estrogen therapy and urinary incontinence: what is the evidence and what do we tell our patients?

Authors:  L Elaine Waetjen; Peter L Dwyer
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-03-15

Review 3.  Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms.

Authors:  Janet P Hapgood; Charu Kaushic; Zdenek Hel
Journal:  Endocr Rev       Date:  2018-02-01       Impact factor: 19.871

4.  Serum estradiol levels are not associated with urinary incontinence in midlife women transitioning through menopause.

Authors:  L Elaine Waetjen; Wesley O Johnson; Guibo Xing; Wen-Ying Feng; Gail A Greendale; Ellen B Gold
Journal:  Menopause       Date:  2011-12       Impact factor: 2.953

5.  Relationship between dietary phytoestrogens and development of urinary incontinence in midlife women.

Authors:  L Elaine Waetjen; Katherine Leung; Sybil L Crawford; Mei-Hua Huang; Ellen B Gold; Gail A Greendale
Journal:  Menopause       Date:  2013-04       Impact factor: 2.953

6.  Risk of urinary incontinence symptoms in oral contraceptive users: a national cohort study from the Swedish Twin Register.

Authors:  Anastasia Iliadou; Ian Milsom; Nancy L Pedersen; Daniel Altman
Journal:  Fertil Steril       Date:  2008-08-15       Impact factor: 7.329

7.  Association of change in estradiol to lower urinary tract symptoms during the menopausal transition.

Authors:  Manish Gopal; Mary D Sammel; Lily A Arya; Ellen W Freeman; Hui Lin; Clarisa Gracia
Journal:  Obstet Gynecol       Date:  2008-11       Impact factor: 7.661

8.  Factors associated with worsening and improving urinary incontinence across the menopausal transition.

Authors:  L Elaine Waetjen; Wen-Ying Feng; Jingjing Ye; Wesley O Johnson; Gail A Greendale; Carolyn M Sampselle; Barbara Sternfield; Siobán D Harlow; Ellen B Gold
Journal:  Obstet Gynecol       Date:  2008-03       Impact factor: 7.661

9.  The mysteries of menopause and urogynecologic health: clinical and scientific gaps.

Authors:  Marianna Alperin; Lindsey Burnett; Emily Lukacz; Linda Brubaker
Journal:  Menopause       Date:  2019-01       Impact factor: 2.953

10.  Topical estrogen, testosterone, and vaginal dilator in the prevention of vaginal stenosis after radiotherapy in women with cervical cancer: a randomized clinical trial.

Authors:  Jumara Martins; Ana Francisca Vaz; Regina Celia Grion; Lúcia Costa-Paiva; Luiz Francisco Baccaro
Journal:  BMC Cancer       Date:  2021-06-10       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.